Zobrazeno 1 - 10
of 56
pro vyhledávání: '"M. D. HUGHES"'
Autor:
V. S. Opollo, X. Wu, M. D. Hughes, S. Swindells, A. Gupta, A. Hesseling, G. Churchyard, S. Kim, R. Lando, R. Dawson, V. Mave, A. Mendoza, P. Gonzales, N. Kumarasamy, F. von Groote-Bidlingmaier, F. Conradie, J. Shenje, S. N. Fontain, A. Garcia-Prats, A. Asmelash, S. Nedsuwan, L. Mohapi, R. Mngqibisa, A. C. Garcia Ferreira, E. Okeyo, L. Naini, L. Jones, B. Smith, N. S. Shah, null on behalf of the A5300/I2003 Study Team
SETTING: The household contacts (HHCs) of multidrug-resistant tuberculosis (MDR-TB) index cases are at high risk of tuberculous infection and disease progression, particularly if infected with the human immunodeficiency virus (HIV). HIV testing is im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60673d6b1436d11f8e905489bc29ee2c
https://europepmc.org/articles/PMC6364692/
https://europepmc.org/articles/PMC6364692/
Autor:
S. Swindells, A. Gupta, S. Kim, M. D. Hughes, J. Sanchez, V. Mave, R. Dawson, N. Kumarasamy, K. Comins, B. Smith, R. Rustomjee, L. Naini, N. S. Shah, A. Hesseling, G. Churchyard, null for the ACTG5300/IMPAACT2003 Phoenix Feasibil
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 22(9)
BACKGROUND: Current guidelines recommend evaluation of household contacts (HHC) of individuals with multidrug-resistant tuberculosis (MDR-TB) but widespread implementation of this policy is challenging. OBJECTIVE: To describe site-level resource util
Autor:
Schlomo Staszewski, Donna Mildvan, Julio S. G. Montaner, Heather R. Ribaudo, Robert T. Schooley, Raphael Dolin, Margaret A. Fischl, Camlin Tierney, John D. Hamilton, T. Creagh, Sunyoung Kim, M. Seligmann, Michael J. Daniels, Anastasios A. Tsiatis, David A. Cooper, David Katzenstein, Janet Darbyshire, Joseph J. Eron, Michael S. Saag, Abdel Babiker, James D. Neaton, A. Cross, Gary Collins, Christine Katlama, M. D. Hughes, Victor DeGruttola, Louis D. Saravolatz, Seth L. Welles, William A. O'Brien, Robert W. Coombs, Douglas D. Richman, Keith Henry, A. Breckenridge, Miklos Salgo, Pamela M. Hartigan, John Bartlett, Andrew M. Hill, Mark D. Moore, James G. Kahn, R.A. DeMasi, L. Struthers, Grossberg Se, Michael Hughes, D. Dawson, Scott M. Hammer
Publikováno v:
AIDS Research and Human Retroviruses. 16:1123-1133
Objective: To evaluate treatment-mediated changes in HIV-1 RNA and CD3 count as prognostic markers and surrogate end points for disease progression (AIDS/death). Methods: Data from 13,045 subjects in all 16 randomized trials comparing nucleoside anal
Publikováno v:
British Journal of Surgery. 87:892-901
Background The appropriate management of melanoma metastatic to inguinal lymph nodes remains controversial. The aim of this study was to identify disease- and treatment-related factors that influence the outcome of patients undergoing therapeutic gro
Publikováno v:
HIV medicine. 11(9)
The aim of the study was to describe growth and body composition changes in HIV-positive children after they had initiated or changed antiretroviral therapy (ART) and to correlate these with viral, immune and treatment parameters.Ninety-seven prepube
Publikováno v:
ANZ Journal of Surgery. 70:438-440
Background: Duplication of the popliteal and superficial femoral veins (PV, SFV) is a normal variant previously reported in up to 25% of limbs. Little clinical significance, however, has been attributed to this apparently common anomaly. The present
Autor:
Ulrike Held, T. R. Fleming, Stephen C. Reingold, John Petkau, Jerry S. Wolinsky, Henry F. McFarland, M. D. Hughes, DH Miller, Gary Cutter
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 14(6)
Background Magnetic resonance imaging (MRI) of lesions in the brain may be the best current candidate for a surrogate biological marker of clinical outcomes in relapsing remitting multiple sclerosis (MS), based on its role as an objective indicator o
Autor:
Y J, Bryson, M, Mirochnick, A, Stek, L M, Mofenson, J, Connor, E, Capparelli, D H, Watts, S, Huang, M D, Hughes, K, Kaiser, L, Purdue, Y, Asfaw, M, Keller, E, Smith, Stephen A, Spector
Publikováno v:
HIV clinical trials. 9(2)
Background: Combination antiretroviral regimens including nelfinavir (NFV) are commonly used in pregnancy. We studied the safety, antiviral effect, and pharmacokinetics of NFV and its M8 metabolite with two dosing regimens in combination with zidovud
Publikováno v:
Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology. 11(2)
We tested the hypothesis that vasoconstriction in response to LBNP or head up tilt would be reflected in a reduction in splanchnic (portal vein) blood flow (PVF) and increases in forearm and total peripheral vascular resistance (TPR). Changes in vasc
Autor:
J M, Raboud, J S, Montaner, S, Rae, J, Kahn, S M, Hammer, D A, Katzenstein, A, Pavia, R, Dolin, M D, Hughes, A, Cross, M, Beltangady, J, Gatell, L, Dunkle, L, Smaldone
Publikováno v:
Antiviral therapy. 2(4)
A meta-analysis of the original data from 2411 patients in the ACTG 116A, ACTG116B/117, ACTG175, BMS010 and CTN002 trials was conducted to improve the estimate of the effect of switching from zidovudine to didanosine on rates of clinical progression,